Skip to content

Efficacy of Hab e Hamal in infertility

Efficacy of Unani Formulation Hab E Hamal in Infertility: a Randomized Placebo Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069582
Enrollment
60
Registered
2024-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified Health Condition 2: N979- Female infertility, unspecified

Interventions

Intervention1: Hab e Hamal 2 tablet BD: 2 tablets of hab e hamal twice daily from day 5 to day 14 for 3 consecutive cycles Control Intervention1: Wheat Tablets 2 BD: 2 Tablets of Wheat twice daily fro

Sponsors

Department of Niswan wa Qabalat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married women in the age group of 18-35 years who were anxious to conceive with or without irregular menstrual cycle Females with or without features of polycystic ovarian disease. Females whose spouse have normal seminogram were included in the study Females with history of not able to conceive even after one year of unprotected intercourse with all normal investigations. Females willing to sign written informed consent.

Exclusion criteria

Exclusion criteria: Females with primary ovarian failure endocrinal disorder systemic illnesses malignancy and on hormonal therapy for anovulation within last 3 months were excluded. Females with any structural and pathological abnormality of reproductive organs will also be excluded. Females with surgical menopause. Mentally retarded females. Females who fail to give consent. Females who fail to follow up.

Design outcomes

Primary

MeasureTime frame
patient shall concieve Timepoint: Assessment of all the parameters at initiation of study at 0 day then at 5th day of 3 consecutive menstrual cycles

Secondary

MeasureTime frame
Menstrual irregularities shall become normalTimepoint: Assessment of all the parameters at initiation of study at 0 day then at 5th day of 3 consecutive menstrual cycles

Countries

India

Contacts

Public ContactTuba Razi

Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University Aligarh

syedanaaz@yahoo.com9412672189

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026